Navigation Links
Yu receives research funding from the Wallace H. Coulter Foundation

HOBOKEN, N.J. -- Stevens Institute of Technology Professor Xiaojun Yu, Ph.D., has received an Early Career Translational Research Award in Biomedical Engineering from the Wallace H. Coulter Foundation. This award will support his research titled, Novel structured nanofibrous scaffolds for bone healing.

Yu, Assistant Professor in the Department of Chemical, Biomedical and Materials Engineering at Stevens Schaefer School of Engineering and Science, is focusing his research on the treatment of bone injury in hard tissue trauma. This type of trauma creates large gaps in the bone tissue, requiring a bone grafting procedure as treatment. It has been found that polymeric nanofiber matrices have the potential to be used as bone grafts; however, due to manufacturing techniques there is restriction in the fabrication of nanofibers into complex three-dimensional (3D) structures necessary for effective treatment, resulting in mechanical properties that are not sufficient for direct bone tissue engineering applications.

Yu has proposed a way to overcome this challenge by incorporating nanofibers onto biodegradable polymeric 3D scaffolds which have optimal porosity due to its open geometrics and large surface area permitting the necessary nutrient transport and cell penetration into the scaffold for successful repair of large bone defects. As a result, biodegradable polymeric 3D scaffolds can provide sufficient mechanical properties and eventually be applied universally in the treatment of bone injuries.

Yu, principal investigator for the research, is working in conjunction with Cato T. Laurencin, M.D., Ph.D., University Professor of Orthopaedic Surgery at the University of Virginia, and Michelle Kofron, Ph.D., recent doctoral graduate of Orthopaedic Surgery at the University of Virginia.


Contact: Maria Molina
Stevens Institute of Technology

Page: 1

Related biology news :

1. DuPonts first biologically derived polymer receives global recognition
2. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
3. Research on antibiotics receives historical recognition
4. Anthrax test, developed by army and CDC, receives FDA approval
5. Research team receives $7.5 million to study cassava
6. Researchers discover way to make cells in the eye sensitive to light
7. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
8. Columbia research lifts major hurdle to gene therapy for cancer
9. Researchers find how protein allows insects to detect and respond to pheromones
10. Researchers Uncover Key Step In Manufacture of Memory Protein
11. Research advances quest for HIV-1 vaccine
Post Your Comments:
(Date:6/9/2016)... in attendance control systems is proud to announce the introduction of fingerprint attendance control ... right employees are actually signing in, and to even control the opening of doors. ... ... ... Photo - ...
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , ... June 23, 2016 , ... ... pleased to announce the launch of their brand, UP4™ Probiotics, into Target stores ... 35 years, is proud to add Target to its list of well-respected retailers. ...
(Date:6/23/2016)... June 23, 2016 Houston Methodist Willowbrook ... Cy-Fair Sports Association to serve as their official ... Houston Methodist Willowbrook will provide sponsorship support, athletic ... with association coaches, volunteers, athletes and families. ... Cy-Fair Sports Association and to bring Houston Methodist ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology: